Flag of Niger

Niger

Destination photograph: Niger
Niger banner Bagzane.jpg · File:Bagzane1.jpg: Jacques Taberlet derivative work: Lkcl it · CC BY-SA 3.0, via Wikimedia Commons. Displayed at a reduced size; no image edits.

Niger travel health

Sources checked

Overview

Prepare for routine immunizations, mosquito-borne infection (nationwide malaria risk), and regionally concentrated hazards (seasonal meningitis in the Sahel “meningitis belt” and localized cholera transmission). Niger requires proof of yellow fever vaccination at entry and medical care access outside major cities can be limited; plan malaria prevention, bring essential medicines, and consider evacuation insurance for remote travel.

Yellow fever — certificate required at entry

Niger requires arriving travellers to present a valid International Certificate of Vaccination (yellow card) for yellow fever (age threshold applied by authorities). The vaccine must be given at least 10 days before travel to count for protection; under the International Health Regulations a single WHO‑recommended dose is considered valid for the life of the person (countries may still require proof on arrival). CDC – Niger travel health ASECNA/Niger points-of-entry guidance WHO/IHR: yellow fever certificate validity.

Vaccinations and entry requirements

Distinguish legal entry rules from clinical recommendations. Get routine vaccines up to date, carry documentation, and discuss additional vaccines with a travel-health clinician at least several weeks before departure.

Routine vaccinations

Ensure routine childhood/adult vaccines are current: MMR (measles), diphtheria-tetanus-pertussis, polio, varicella, and influenza as appropriate. These are standard travel‑health measures and protect against circulating and outbreak-prone respiratory and vaccine‑preventable diseases. CDC – routine vaccines and travel advice.

Hepatitis A and typhoid

Hepatitis A vaccine is recommended for all unvaccinated travelers ≥1 year old (and for infants 6–11 months in certain circumstances). Typhoid vaccine is recommended for most travelers to Niger, especially if you will eat outside major hotels or stay with local families. Practice strict food‑and‑water hygiene in any case. CDC – Hepatitis A, typhoid.

Meningococcal vaccine (seasonal / area-specific)

Parts of Niger lie inside the African “meningitis belt.” Vaccination against meningococcal disease is recommended for travelers to areas of the belt during the dry season (roughly December–June) or for those in close contact with local populations; targets, serogroups and vaccine products vary by campaign and year. Discuss timing and target groups with your provider. CDC – meningococcal recommendation WHO Regional Office for Africa – meningitis.

Polio

Poliovirus has been detected in the region in recent reporting. Adults with a prior complete childhood series may be advised to receive a single lifetime inactivated polio vaccine (IPV) booster before travel; unvaccinated or incompletely vaccinated travelers should complete a full series. Check country- and departure‑country requirements if you will be coming from or transiting polio‑affected areas. CDC – polio and travel.

Rabies (pre‑exposure consideration)

Dog rabies is present in Niger; pre‑exposure rabies vaccination should be considered for travelers who will do animal‑exposure work, spend prolonged time in remote areas, or may not have rapid access to high-quality post‑exposure prophylaxis (RIG and vaccine). Even if vaccinated, prompt wound washing and local medical evaluation are required after any bite or scratch. CDC Yellow Book – rabies CDC – country rabies note.

Other health risks

Non‑vaccine risks that commonly affect travellers to Niger include malaria, diarrhoeal disease, and limited availability of specialist medical care outside Niamey and other large towns.

Malaria

Malaria transmission occurs throughout Niger, principally Plasmodium falciparum. CDC recommends that all travelers to Niger take effective antimalarial chemoprophylaxis; commonly used options include atovaquone‑proguanil, doxycycline, mefloquine, or tafenoquine depending on medical history and contraindications. Use mosquito‑bite prevention (insecticide‑treated nets, repellents, clothing) day‑and‑night as appropriate, and seek urgent care for any fever during travel or up to a year after return. WHO – Niger malaria profile CDC – malaria chemoprophylaxis.

Traveler’s diarrhea and cholera risk

Unsafe food and water are common causes of diarrhoeal illness. Practice careful food and water precautions. CDC identifies localized areas of active cholera transmission in Niger (noting recent cases in some regions); oral cholera vaccine may be considered for travelers (including children) going to areas of active transmission. CDC – cholera and travel WHO Regional Office for Africa – cholera preparedness.

Healthcare access and medical evacuation

Medical facilities and supplies are concentrated in Niamey and larger regional centers; advanced care and specialist services are limited elsewhere. Travelers should carry necessary medications (with prescriptions), a letter describing medical conditions, and consider travel health/medical‑evacuation insurance. Maintain a list of local medical contacts and the nearest embassy or consulate. CDC – health systems and preparedness.

Current health alerts

Only items with clear, current evidence are listed here.

Localized cholera transmission

CDC reports localized active cholera transmission in parts of Niger (noting recent activity in divisions such as Tahoua and Zinder); travelers to these specific areas may face higher diarrhoeal risk and local public‑health responses. Check local health notices and avoid untreated water and street food in affected districts. CDC – Niger travel health notices (cholera).

Poliovirus detection – elevated attention

CDC notes that poliovirus has been identified in the region within the past year; travelers to Niger should ensure polio vaccination is up to date and follow destination or departure-country polio vaccination advice. CDC – polio and travel advice.

Seasonal meningitis risk (December–June)

During the dry season (roughly December through June) meningococcal disease incidence rises in the African meningitis belt that includes parts of Niger; vaccination is recommended for travel to belt areas during this season or when there is an active outbreak. Monitor local notices if you travel in the dry season. CDC – meningitis belt guidance WHO Regional Office for Africa – meningitis.

Before you travel

See a travel‑medicine clinician 4–8 weeks before departure when possible; allow time for vaccine series and personalized prescribing for malaria and other prevention.

Preparation checklist

At a minimum: confirm yellow fever vaccination and carry the International Certificate of Vaccination; update routine vaccines; get hepatitis A and typhoid if not immune; discuss rabies pre‑exposure if you will be at risk; obtain an appropriate malaria prescription and practice bite avoidance; pack a traveler’s first‑aid kit and prescriptions; buy travel health/evacuation insurance; register with your embassy if desired. For site‑specific alerts (cholera, meningitis season, polio), check national health authorities and WHO/CDC updates close to departure. CDC – Niger travel health WHO – malaria profile.

This information summarizes published public-health guidance. A travel-health professional can advise on your itinerary, medical history and vaccination needs.

AI-generated landscape illustration inspired by Niger
AI-generated illustration inspired by Niger.